Neoplasia in dogs: medicines most often reported

2,111 FDA reports in dogs mention neoplasia. These are the medicines named most often in those reports.

Oclacitinib (Apoquel)
484 1.7% of its reports
Milbemycin Oxime + Spinosad (Trifexis)
265 0.2% of its reports
Carprofen (Rimadyl)
248 0.5% of its reports
Ivermectin + Pyrantel (Heartgard Plus)
191 0.1% of its reports
Cyclosporine (Atopica)
136 0.9% of its reports
Afoxolaner (NexGard)
80 0.1% of its reports
Moxidectin (ProHeart 6)
78 0.2% of its reports
Spinosad (Comfortis)
77 0.1% of its reports
Milbemycin Oxime + Praziquantel (Interceptor Plus)
70 0.2% of its reports
Fluralaner (Bravecto)
65 0.1% of its reports
Bedinvetmab (Librela)
64 0.3% of its reports
Deracoxib (Deramaxx)
61 0.6% of its reports
Milbemycin Oxime (Interceptor)
48 0.2% of its reports
Lokivetmab (Cytopoint)
43 0.7% of its reports
Grapiprant (Galliprant)
40 0.5% of its reports
Gabapentin
39 0.4% of its reports
Trilostane (Vetoryl)
38 0.3% of its reports
Polysulfated Glycosaminoglycan
36 0.7% of its reports
Prednisone
33 0.4% of its reports
Maropitant (Cerenia)
33 0.3% of its reports
Lufenuron + Milbemycin Oxime (Sentinel)
28 0.1% of its reports
Meloxicam (Metacam)
27 0.3% of its reports
Imidacloprid + Moxidectin (Advantage Multi)
25 0.2% of its reports
Selamectin (Revolution)
23 0.1% of its reports
Firocoxib (Previcox)
23 0.3% of its reports
Amoxicillin + Clavulanate (Clavamox)
21 0.4% of its reports
Diphenhydramine
20 0.4% of its reports
Tramadol
20 0.5% of its reports